ZAQS.ORG

Friday, July 24, 2026 2:27 AM ET

CNBC - Health

Cyclospora outbreak tests RFK Jr.'s promise to rebuild trust in CDC

15 hours ago

Eli Lilly says it will file for approval of next-generation obesity drug in 2027

17 hours ago

Ozempic face? Botox boom boosted by 'sagging face' trend, Swiss firm says

18 hours ago

What Trump's generic drug tariffs could mean for patients, drugmakers and prices

20 hours ago

RFK Jr. says cyclospora outbreak is 'under control'

2 days ago

Cardinal Health's latest deals won't move the needle overnight. They still matter.

2 days ago

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

2 days ago

The FDA made a reversal on cyclosporiasis, but it still thinks iceberg lettuce is to blame

2 days ago

What to know about testosterone replacement as U.S. military plans to test troops

3 days ago

Market case for psychedelic drugs to treat mental health gets a big buy signal

3 days ago

Fat cat? Weight-loss drugs may be coming for your overweight pet

6 days ago

Trump rips Canada for wildfire smoke, threatens to raise tariffs

6 days ago

Taco Bell says it has removed lettuce linked to cyclosporiasis outbreak from its restaurants

6 days ago

World's largest olive oil company says market has 'definitively' entered new phase

7 days ago

Buy the contractor before the renovation is complete: This stock's next growth phase is taking shape

7 days ago

3 of our stocks rode the AI rally, while 3 others fell out of favor since last month

7 days ago

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion

7 days ago

UnitedHealth beats quarterly estimates, hikes profit outlook

7 days ago

J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways

8 days ago

Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up

9 days ago

A tiny GLP-1 implant is the latest bet to help patients maintain weight loss

9 days ago

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium too vulnerable?

12 days ago

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer

13 days ago

AstraZeneca stock drops after clinical trial miss deals rare blow to pharma powerhouse

13 days ago

Employers aren't expanding coverage of GLP-1 obesity drugs, survey says

14 days ago

Jim Cramer says these are the 5 stocks to buy during this market rotation

17 days ago

Ebola outbreak harder to contain after USAID, Western aid cuts, experts say

17 days ago

Jim Cramer says this former Covid market darling is finally investable again

22 days ago

Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs

22 days ago

FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes

23 days ago

Cramer says this aerospace stock is significantly undervalued, sees 35% upside

23 days ago

Medicare will start covering obesity drugs. Here's what patients should know

23 days ago